Centene Corporation (CNC)
Centene Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Centene Corporation (CNC) is a Medical - Healthcare Plans company based in US with a market capitalization of $33.4B. Revenue grew 19.4% year-over-year and the company generated $4.3B in free cash flow. This page tracks CNC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 60.4K employees · IPO Dec 13, 2001
Valuation
Valuation & price
$58.27as of May 17, 2026· -15.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.67
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$33.4B
Market cap
19.4%
Revenue growth (YoY)
12.2%
Gross margin
$4.3B
Free cash flow (USD)
$889M
Net debt
-5.9%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed Apr 28, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Centene Corporation's market cap?
Centene Corporation (CNC) has a market capitalization of $33.4B.
What is CNC's P/E ratio?
A meaningful P/E ratio is not available for CNC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is CNC's price-to-book (P/B) ratio?
CNC trades at 1.67 times book value per share.
Are insiders buying CNC stock?
SEC Form 4 filings show no open-market insider buys at Centene Corporation in the last 90 days (1 sell).
Same arena
Related companies in Medical - Healthcare Plans
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.